Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Exposure to hazardous substances in a standard molecular biology laboratory environment: evaluation of exposures in IARC laboratories.

Chapot B, Secretan B, Robert A, Hainaut P.

Ann Occup Hyg. 2009 Jul;53(5):485-90. doi: 10.1093/annhyg/mep029. Epub 2009 May 27.

PMID:
19474073
2.

The methyl methanesulfonate induced S-phase delay in XRCC1-deficient cells requires ATM and ATR.

Brem R, Fernet M, Chapot B, Hall J.

DNA Repair (Amst). 2008 Jun 1;7(6):849-57. doi: 10.1016/j.dnarep.2008.02.002. Epub 2008 Mar 28.

PMID:
18375193
3.
4.

The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.

Brem R, Cox DG, Chapot B, Moullan N, Romestaing P, Gérard JP, Pisani P, Hall J.

Carcinogenesis. 2006 Dec;27(12):2469-74. Epub 2006 Jul 8.

PMID:
16829685
5.

ATM polymorphisms as risk factors for prostate cancer development.

Angèle S, Falconer A, Edwards SM, Dörk T, Bremer M, Moullan N, Chapot B, Muir K, Houlston R, Norman AR, Bullock S, Hope Q, Meitz J, Dearnaley D, Dowe A, Southgate C, Ardern-Jones A, Easton DF, Eeles RA, Hall J.

Br J Cancer. 2004 Aug 16;91(4):783-7.

6.

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.

Angèle S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gérard JP, Hall J.

Cancer Res. 2003 Dec 15;63(24):8717-25.

7.

Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia.

Wild CP, Yin F, Turner PC, Chemin I, Chapot B, Mendy M, Whittle H, Kirk GD, Hall AJ.

Int J Cancer. 2000 Apr 1;86(1):1-7.

8.

Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.

Wild CP, Hasegawa R, Barraud L, Chutimataewin S, Chapot B, Ito N, Montesano R.

Cancer Epidemiol Biomarkers Prev. 1996 Mar;5(3):179-89.

9.

Aflatoxin exposure and cytogenetic alterations in individuals from the Gambia, West Africa.

Miele M, Donato F, Hall AJ, Whittle H, Chapot B, Bonatti S, De Ferrari M, Artuso M, Gallerani E, Abbondandolo A, Montesano R, Wild CP.

Mutat Res. 1996 Feb 1;349(2):209-17.

PMID:
8600352
10.

Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.

Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, Wogan GN, Whittle H, Montesano R, Groopman JD.

Cancer Epidemiol Biomarkers Prev. 1992 Mar-Apr;1(3):229-34.

11.

Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment.

Wild CP, Jiang YZ, Sabbioni G, Chapot B, Montesano R.

Cancer Res. 1990 Jan 15;50(2):245-51.

PMID:
2104776
12.

Application of antibody methods to the detection of aflatoxin in human body fluids.

Wild CP, Chapot B, Scherer E, Den Engelse L, Montesano R.

IARC Sci Publ. 1988;(89):67-74.

PMID:
3198233
13.

Monitoring of individual human exposure to aflatoxins (AF) and N-nitrosamines (NNO) by immunoassays.

Wild CP, Umbenhauer D, Chapot B, Montesano R.

J Cell Biochem. 1986;30(2):171-9.

PMID:
3700493

Supplemental Content

Loading ...
Support Center